Winston Pharmaceuticals, Inc. (WPHM) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 19 transactions totaling $21.8K, demonstrating a bearish sentiment with -$5.0K in net insider flow. The most recent transaction on Jul 20, 2010 involved a purchase of 10,000 shares valued at $4.4K.
No significant insider buying has been recorded for WPHM in the recent period.
No significant insider selling has been recorded for WPHM in the recent period.
Based on recent SEC filings, insider sentiment for WPHM is bearish with an Insider Alignment Score of 38/100 and a net flow of -$5.0K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Winston Pharmaceuticals, Inc. (WPHM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading WPHM stock, having executed 19 transactions in the past 90 days. The most active insider is Joel E. Bernstein (Executive), who has made 2 transactions totaling $92.7K.
Get notified when executives and directors at WPHM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 20, 2010 | Stuart Penneys Neal | Executive | Purchase | 10,000 | $0.44 | $4.4K | |
| Jul 20, 2010 | Stuart Penneys Neal | Executive | Purchase | 10,000 | $0.40 | $4.0K | |
| May 19, 2010 | Investments Trust Frost Gamma | Executive | Sale | 17,794,862 | $N/A | $0 | |
| May 19, 2010 | Uppaluri Subbarao V | Executive | Sale | 209,449 | $N/A | $0 | |
| May 19, 2010 | E. Bernstein Joel | Executive | Purchase | 18,399,271 | $N/A | $0 | |
| Dec 16, 2009 | Md Et Al Frost Phillip | Executive | Sale | 1,741 | $0.35 | $609 | |
| Oct 16, 2009 | B. Phillips Scott | Executive | Sale | 6,500 | $0.77 | $5.0K | |
| Oct 16, 2009 | B. Phillips Scott | Executive | Sale | 13,500 | $0.58 | $7.8K | |
| Oct 16, 2009 | B. Phillips Scott | Executive | Option Exercise | 25,000 | $0.28 | $7.0K | |
| Sep 24, 2009 | Investments Trust Frost Gamma | Executive | Conversion | 4,583,000 | $N/A | $0 | |
| Sep 24, 2009 | Investments Trust Frost Gamma | Executive | Conversion | 12,476,000 | $N/A | $0 | |
| Sep 24, 2009 | Uppaluri Subbarao V | Executive | Conversion | 127,000 | $N/A | $0 | |
| Sep 24, 2009 | L. Halpryn Glenn | Executive | Conversion | 229,000 | $N/A | $0 | |
| May 1, 2009 | B. Phillips Scott | Executive | Option Exercise | 158,859 | $0.28 | $44.5K | |
| Jan 12, 2009 | E. Bernstein Joel | Executive | Option Exercise | 231,670 | $0.40 | $92.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 3 | $144.1K | 86.8% |
Sale(S) | 5 | $13.4K | 8.1% |
Purchase(P) | 3 | $8.4K | 5.1% |
Conversion(C) | 4 | $0 | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Insider selling pressure at Winston Pharmaceuticals, Inc. has increased, with 8 insiders executing 19 transactions across all time. Total sales of $13.4K significantly outpace purchases of $8.4K, resulting in a net outflow of $5.0K. This selling activity appears largely discretionary, which may warrant closer attention from investors.